Oorsprong van het eerstegraads netwerk van Marc Hasler
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
THERAMetrics holding AG
 THERAMetrics holding AG Pharmaceuticals: MajorHealth Technology THERAMetrics holding AG is an independent biotech company, which discovers drugs for patients suffering from rare diseases. The company was founded by Fabio Cavalli, Vera Cavalli, Patrick Pozzorini, Dorian Bevec and Michael von und zu Liechtenstein on February 9, 2001 and is headquartered in Stans, Switzerland.
5
| Extinct | Pharmaceuticals: Major | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Marc Hasler via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Industrie-und Finanzkontor | Chairman Chief Executive Officer | ||
| University of Vienna | College/University | Undergraduate Degree | |
TOLREMO therapeutics AG
 TOLREMO therapeutics AG Miscellaneous Commercial ServicesCommercial Services TOLREMO therapeutics AG engages in discovering and developing therapies for treating cancer patients. The firm serves on academic research laboratories, flourishing life sciences spin-offs and cutting-edge technology platforms. The company was founded by Stefanie Flückiger-Mangual, Wilhelm Krek, Karl-Heinz Altmann, Isaac Kobrin, and Emmanuel Savioz in March 2017 and is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
| Swiss Cancer League | President | ||
| University of Bern | College/University | Doctorate Degree | |
| University of St. Gallen | College/University | Corporate Officer/Principal | |
| University of Basel | College/University | Undergraduate Degree | |
| BIOPHARMAinvest AG | Chairman | ||
SuppreMol GmbH
 SuppreMol GmbH Pharmaceuticals: MajorHealth Technology SuppreMol GmbH engages in the development and use of active substances for the therapy of autoimmune diseases and allergies, as well as the research on and development of medicinal products. It also produces medicines through licensed manufacturers. The products are supplied via pharmaceutical wholesale. The company was founded by Robert Huber, Uwe Jacob, and Peter Sondermann in 2002 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Founder | |
Proteros biostructures GmbH
 Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Proteros biostructures GmbH is a holding company which serves as a discovery service business. Its business areas are Discovery Pipeline, Discovery Services and Science & Technology. The Discovery Pipeline focuses on protein biochemistry, X-ray crystallography, biophysics, computational chemistry and property driven medicinal chemistry, Discovery Services offers drug discovery services with expertise and proprietary technologies for protein production, protein structure analysis, kinetic and thermodynamic profiling and Science & Technology segment focuses on industrialized structure-guided lead development infrastructure. The company was founded by Robert Huber and Torsten Neuefeind in 1999 and is headquartered in Martinsried, Germany. | Medical/Nursing Services | Founder | |
| Technische Universität München | College/University | Corporate Officer/Principal | |
| Korean German Instittue of Technology | College/University | Corporate Officer/Principal | |
| Max Planck Institute of Biochemistry | College/University | Chief Tech/Sci/R&D Officer | |
| Universitat Autònoma de Barcelona | College/University | Corporate Officer/Principal | |
| University of Seville | College/University | Corporate Officer/Principal | |
| University of Cardiff | College/University | Corporate Officer/Principal | |
| University of Duisburg-Essen | College/University | Corporate Officer/Principal | |
ProteoMediX AG
 ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Zwitserland | 8 |
| Duitsland | 6 |
| Liechtenstein | 3 |
| Spanje | 3 |
| Oostenrijk | 2 |
Sectoraal
| Consumer Services | 12 |
| Health Technology | 4 |
| Commercial Services | 2 |
| Health Services | 2 |
Operationeel
| Corporate Officer/Principal | 8 |
| Director/Board Member | 7 |
| Founder | 4 |
| Chairman | 3 |
| Doctorate Degree | 2 |
Sterkste connecties
- Beurs
- Insiders
- Marc Hasler
- Bedrijfsconnecties
